Literature DB >> 7743381

1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line.

F S Fan1, W C Yu.   

Abstract

Cells of a breast adenocarcinoma cell line, CAMA-IEe, were found to contain a moderate concentration of 1,25-dihydroxyvitamin D3[1,25(OH)2D3] receptors. The receptors' dissociation constant calculated by Scatchard analysis was 4.1 x 10(-10) M. These receptors sedimented at around 4.0 S position on a linear 5-20% sucrose density gradient and exhibited an apparent molecular weight of about 46 kDa. Receptor concentration was found to be highest in the early stages of cell growth, decreased continuously when cells were actively growing, and reached the lowest level at confluence. Suppression of cell growth, of DNA synthesis, and of the phosphorylation of retinoblastoma protein by 1,25(OH)2D3 at concentrations about 10(-7) M were observed. Treatment with 10(-7) M 1,25(OH)2D3 for 12 hr or longer caused elevation of cytosolic free calcium in CAMA-IEe cells. These results show that CAMA-IEe cell growth is suppressed by 1,25(OH)2D3 and that the suppression is possibly mediated through calcium mobilization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743381     DOI: 10.3109/07357909509094463

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

Review 1.  The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.

Authors:  Aruna V Krishnan; Srilatha Swami; David Feldman
Journal:  Steroids       Date:  2012-07-16       Impact factor: 2.668

2.  Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.

Authors:  Rebecca L Hillyer; Padma Sirinvasin; Madhura Joglekar; Robert A Sikes; Kenneth L van Golen; Anja Nohe
Journal:  Clin Exp Metastasis       Date:  2012-05-20       Impact factor: 5.150

Review 3.  Rationale for the development and current status of calcitriol in androgen-independent prostate cancer.

Authors:  Tomasz M Beer; Anne Myrthue; Kristine M Eilers
Journal:  World J Urol       Date:  2005-01-25       Impact factor: 4.226

4.  Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.

Authors:  Kun-Chun Chiang; Chun-Nan Yeh; Jun-Te Hsu; Ta-sen Yeh; Yi-yin Jan; Chun-Te Wu; Huang-Yang Chen; Shyh-Chuan Jwo; Masashi Takano; Atsushi Kittaka; Horng-Heng Juang; Tai C Chen
Journal:  Cell Cycle       Date:  2013-04-02       Impact factor: 4.534

Review 5.  Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.

Authors:  Aruna V Krishnan; Srilatha Swami; David Feldman
Journal:  J Steroid Biochem Mol Biol       Date:  2012-08-23       Impact factor: 4.292

6.  Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells.

Authors:  T B Moore; H P Koeffler; J M Yamashiro; R K Wada
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

Review 7.  Mechanistic Effects of Calcitriol in Cancer Biology.

Authors:  Lorenza Díaz; Mauricio Díaz-Muñoz; Ana Cristina García-Gaytán; Isabel Méndez
Journal:  Nutrients       Date:  2015-06-19       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.